AP
CAH icon

Anchyra Partners’s Cardinal Health CAH Stock Holding History

Anchyra Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+940
New +$195K 0.05% 294

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Anchyra Partners's CAH Position: Q2 2026 in Review

Anchyra Partners opened a new position in Cardinal Health (CAH) in Q2 2026: 940 shares worth $223K. The stake represents 0.05% of the portfolio and ranks #294 among its holdings.

857 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Anchyra Partners held 940 shares of Cardinal Health worth $223K as of Q2 2026.
  • Cardinal Health was a new Anchyra Partners position in Q2 2026.
  • Cardinal Health made up 0.05% of Anchyra Partners's portfolio in Q2 2026, its #294 holding.
  • 857 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.